Professor of Surgery
Director, Stereotactic and Functional Neurosurgery
Internationally renowned neurosurgeon Peter Warnke, MD, has performed more than 5,000 stereotactic surgeries and more than 2,000 brain tumor surgeries. Dr. Warnke provides neurosurgical care for the treatment of:
He routinely performs neurosurgical procedures with proven expertise, including:
Dr. Warnke routinely performs MRI-guided laser ablation for epilepsy and tumors, and is actively researching gene therapy for brain tumors (Lancet Oncology 2013).
He has special expertise in stereotactic radiosurgery, including interstitial radiosurgery and stereotactically guided endoscopy. Dr. Warnke was one of the first neurosurgeons to use interstitial stereotactic radiosurgery for the treatment of gelastic epilepsy and hypothalamic hamartomas. He also provides care for patients with pain syndromes, including trigeminal neuralgia and neuropathic pain.
Additionally, Dr. Warnke has special training in molecular imaging with a focus on surgical planning and individualized treatment. He is one of few neurosurgeons in the United States who has experience with dopamine transporter imaging (DAT-SPECT). Specifically, Dr. Warnke is studying the use of DAT-SPECT to predict response to deep brain stimulation (DBS) for Parkinson’s disease.
He is also researching the development of biological and minimally invasive treatments for epilepsy, movement disorders and brain tumors. Additionally, he is studying the tumor physiology of medulloblastomas and their relation to drug delivery in pediatric brain tumors.
Dr. Warnke is the associate editor of the Journal of Neurology, Neurosurgery and Psychiatry, which has one of the highest impact factors among neurosurgical journals. He also sits on the steering committees of several clinical trials, and has received ongoing extramural research funding for 20 years.
Center for Advanced Medicine
Year Started Practice
Medical School and Internship
University of Freiburg, Germany
University Hospital Homburg, Germany
Northwestern University, Chicago
American Association of Neurological Surgeons
Office Postal Address
Peter Warnke, MD
Request an appointment online
Read More About Dr. Warnke
Dr. Warnke and his colleagues are among the first in the U.S. to successfully use new directional DBS technology.
For the first time in more than 40 years, Michael Segreto began to experience troubling seizure activity. After undergoing stereoelectroencephalography (SEEG) and laser ablation surgery, performed by Dr. Warnke, Michael is seizure-free once again.
At age 70, Cheng Xiu Xu's Parkinson's disease symptoms and medication side effects left her unable to perform familiar activities, including playing her favorite sport: ping-pong. Just two days after Dr. Warnke placed a DBS implant, Xu was able to play ping-pong again. Read her story.
Dr. Warnke worked with a multidisciplinary team of specialists to diagnose and treat Leo Galati's primary central nervous system lymphoma (PCNSL), a rare tumor that occurs when cancerous lymphocytes are found in the brain, spinal cord or cerebrospinal fluid. Read Leo's story.
Patrick O'Brien has essential tremor. After hearing Dr. Warnke speak at an event, he came the University of Chicago Medicine for DBS. Now he's living without tremors. Read Patrick's story.
Using functional MRI, Dr. Warnke was able to skillfully pinpoint critical anatomy surrounding a meningioma in Vaughn Atkins’ brain. With Dr. Warnke’s surgical precision, Vaughn avoided loss of motor function and even regained the movement he lost as a result of the pressure the tumor placed on his brain. Read Vaughn's story.
Dr. Warnke precisely targeted a quiet grouping of neurons and implanted an electrode in Betty Bertram's brain to control the essential tremor afflicting the left side of her body. Read Betty's story.
View a partial list of Dr. Warnke's publications through the National Library of Medicine’s publication database.